June 23 @ 7:00 pm – 8:30 pm America/Orlando
Supported By: An independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.
Program Description
Join us for an exciting symposium featuring perspectives and recommendations from 2 renowned obesity experts with extensive experience in research and clinical care. This interactive symposium will disseminate cutting-edge information and expert perspectives on translating practice-changing data on novel therapeutic targets—like glucagon agonism—and treatments for obesity into clinical practice.
This information is being distributed by the American Diabetes Association as a sponsor benefit. Reference to commercial products, processes, or services by trade name, trademark, manufacturer, or otherwise, does not necessarily constitute or imply its endorsement, recommendation, or favoring by the American Diabetes Association. The views and opinions of sponsors expressed herein do not necessarily state or reflect those of the American Diabetes Association, and shall not be used for advertising or product endorsement purposes.
Speakers
Domenica M. Rubino, MD
Washington Center for Weight Management and Research
Director
Arlington, VA
Jaime Almandoz, MD, MBA, FTOS
Medical Director, Weight Wellness Program
Associate Professor of Internal Medicine
Division of Endocrinology
University of Texas Southwestern Medical Center
Dallas, TX